Article Versions Notes

Courlet P, Cardoso E, Bandiera C, Stravodimou A, Zurcher J-P, Chtioui H, Locatelli I, Decosterd LA, Darnaud L, Blanchet B, et al. Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer. Pharmaceutics. 2022; 14(7):1317. https://doi.org/10.3390/pharmaceutics14071317

Courlet, Perrine, Evelina Cardoso, Carole Bandiera, Athina Stravodimou, Jean-Philippe Zurcher, Haithem Chtioui, Isabella Locatelli, Laurent Arthur Decosterd, Léa Darnaud, Benoit Blanchet, and et al. 2022. "Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer" Pharmaceutics 14, no. 7: 1317. https://doi.org/10.3390/pharmaceutics14071317

Courlet, P., Cardoso, E., Bandiera, C., Stravodimou, A., Zurcher, J.-P., Chtioui, H., Locatelli, I., Decosterd, L. A., Darnaud, L., Blanchet, B., Alexandre, J., Wagner, A. D., Zaman, K., Schneider, M. P., Guidi, M., & Csajka, C. (2022). Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer. Pharmaceutics, 14(7), 1317. https://doi.org/10.3390/pharmaceutics14071317